Rezultati - Matthew R. Netherton

In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease od Brian L. Lin, Damian Matera, Julia F. Doerner, Nan Zheng, Donato del Camino, Sumita Mishra, Bian Hong, Svetlana Zeveleva, Xiao-guang Zhen, Nathaniel T. Blair, Jayhong A. Chong, David P. Hessler, Djahida Bedja, Guangshuo Zhu, Grace K. Muller, Mark J. Ranek, Lynn Pantages, Mary McFarland, Matthew R. Netherton, Angela Berry, Diane Wong, Georg Rast, Hu Sheng Qian, Steven M. Weldon, Jay J. Kuo, Achim Sauer, Chris Sarko, Magdalene M. Moran, David A. Kass, Steven S. Pullen